Chiglitazar Added to Metformin for Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

533

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

February 10, 2023

Study Completion Date

February 10, 2023

Conditions
Type 2 Diabetes
Interventions
DRUG

Chiglitazar 32mg

Administrated once daily

DRUG

Chiglitazar 48mg

Administrated once daily

DRUG

Placebo

Placebo of Chiglitazar

DRUG

Metformin Hydrochloride

most tolerable dose

Trial Locations (50)

Unknown

Hefei Second People's Hospital, Hefei

The First Affiliated Hospital of Anhui Medical University, Hefei

The Second Affiliated Hospital of Anhui Medical University, Hefei

Yijishan Hospital of Wannan Medical College, Wuhu

Beijing Chaoyang Hospital, Capital Medical University, Beijing

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Luhe Hospital, Capital Medical University, Beijing

Beijing Tongren Hospital, Capital Medical University, Beijing

Beijing Tsinghua Chang Gung Memorial Hospital, Beijing

Beijing University First Hospital, Beijing

Chinese People's Liberation Army Rocket Army Characteristic Medical Center, Beijing

Peking University People's Hospital, Beijing

Xuanwu Hospital, Capital Medical University, Beijing

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

Three Gorges Hospital Affiliated to Chongqing University, Wanzhou

Shenzhen People's Hospital, Shenzhen

Union Shenzhen Hospital of Huazhong University of Science and Technology, Shenzhen

Harrison International Peace Hospital, Hengshui

The Second Hospital of Hebei Medical University, Shijiazhuang

The Third Hospital of Hebei Medical University, Shijiazhuang

Huaihe Hospital of Henan University, Kaifeng

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

The Third People's Hospital of Luoyang City, Luoyang

Xinxiang Central Hospital, Xinxiang

The First People's Hospital of Chenzhou City, Chenzhou

Yueyang Second People's Hospital, Yueyang

Zhuzhou Central Hospital, Zhuzhou

Inner Mongolia Baotou Steel Hospital, Baotou

The First People's Hospital of Huai'an, Huaian

Jiangsu Provincial People's Hospital, Nanjing

Nanjing First Hospital, Nanjing

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

Yifu Hospital Affiliated to Nanjing Medical University, Nanjing

Affiliated Hospital of Xuzhou Medical University, Xuzhou

The First Hospital of Jilin University, Harbin

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

The Second Hospital of Jilin University, Harbin

Panjin Liaoyou Baoshihua Hospital, Panjin

Jinan Central Hospital, Jinan

Qilu Hospital of Shandong University, Jinan

Affiliated Hospital of Jining Medical College, Shandong Province, Jining

Qingdao University Hospital, Qingdao

Gongli Hospital, Pudong New Area, Shanghai, Shanghai

Shanghai Minhang District Central Hospital, Shanghai

Shanghai Pudong Hospital, Shanghai

Shanghai Seventh People's Hospital, Shanghai

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

Central Hospital of Yuncheng City, Shanxi Province, Yuncheng

Tangshan Workers' Hospital, Tangshan

Huzhou Central Hospital, Huzhou

Sponsors
All Listed Sponsors
lead

Chipscreen Biosciences, Ltd.

INDUSTRY

NCT04807348 - Chiglitazar Added to Metformin for Type 2 Diabetes | Biotech Hunter | Biotech Hunter